Artificial Intelligence in Mental Healthcare: Potential Applications and New Frontiers
暫譯: 心理健康護理中的人工智慧:潛在應用與新前沿

Bhavnani, Shivan, McKim, Ryan

  • 出版商: CRC
  • 出版日期: 2026-03-10
  • 售價: $6,630
  • 貴賓價: 9.8$6,497
  • 語言: 英文
  • 頁數: 190
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 1032932880
  • ISBN-13: 9781032932880
  • 相關分類: Machine Learning
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

As the healthcare industry begins to digest recent advances in artificial intelligence (AI), this book unveils the potential impact of AI on mental and behavioral healthcare. It covers existing and potential applications of AI in addition to its main subfields of machine learning (generative AI included), natural language processing (NLP), and predictive analytics.

This book navigates the intricacies of AI in all stages of the patient journey from diagnosis, treatment, and prevention, offering a holistic view of the future of mental and behavioral healthcare. It explores how AI is revolutionizing key therapeutic areas within mental health, like substance misuse, anxiety disorders, and mood disorders. It also assesses use cases in back office and non-patient-facing areas including reimbursement processes, data collection and management, and revenue cycle management. Chapters are supplemented with a variety of real-world case studies that highlight the practical implications of AI in clinical and non-clinical settings.

This work is relevant for healthcare clinicians, innovators, researchers, healthcare executives, and students navigating the intersection of AI and mental and behavioral healthcare.

商品描述(中文翻譯)

隨著醫療保健行業開始消化近期在人工智慧(AI)方面的進展,本書揭示了AI對心理和行為健康護理的潛在影響。它涵蓋了AI的現有和潛在應用,以及其主要子領域,包括機器學習(包含生成式AI)、自然語言處理(NLP)和預測分析。

本書探討了AI在患者旅程各階段的複雜性,從診斷、治療到預防,提供了心理和行為健康護理未來的整體視角。它探索了AI如何徹底改變心理健康中的關鍵治療領域,如物質濫用、焦慮症和情緒障礙。它還評估了在後台和非面對患者的領域中的使用案例,包括報銷流程、數據收集和管理,以及收入週期管理。各章節附有多個真實案例研究,突顯了AI在臨床和非臨床環境中的實際應用。

本書對於醫療保健臨床醫生、創新者、研究人員、醫療保健高管以及在AI與心理和行為健康護理交集上探索的學生都具有相關性。

作者簡介

Shivan Bhavnani is a healthcare investor focused on reshaping mental healthcare. As a Partner at Evio VC, he backs early-stage companies innovating in mental healthcare. He also founded GIMBHI, an independent research institute whose insights have appeared in Nature, Axios, Business Insider, Entrepreneur, and Bessemer Venture Partners.

A regular speaker at global health-tech conferences, Shivan has served as a strategic advisor at various startups and organizations including One Mind Accelerator, ReKlame Health, and others. Over the past decade, Shivan has worked across venture capital, biotech, and credit.

Shivan earned an MBA from Duke University and a BA from Wesleyan University. Additionally, he completed an innovation fellowship at Columbia Psychiatry. He is also a Chartered Alternative Investment Analyst (CAIA).

Ryan McKim, Psy.D., is a Venture Advisor to Innovative Growth Capital within GIMBHI's advisor network, where he guides founders on capital strategy and market access for breakthrough mental health technologies. A seasoned health-tech operator and investor with more than two decades in the sector, he has helped scale digital-therapeutic, neurotechnology, and psychedelic-medicine startups from seed through commercialization.

Alongside his investment work, Ryan remains an active clinician. Currently serving as supervisor for Marin County's substance use treatment program for adults with complex co-occurring substance use disorders and serious mental illness, as well as a private integrative psychiatry clinic, and formerly the Department of Psychiatry at California Pacific Medical Center, where he delivered comprehensive neuropsychological evaluations and evidence-based interventions for adults with neurodegenerative and CNS disorders, TBI, and mood disorders. His dual perspective - clinician and venture capitalist - allows him to translate rigorous neuroscience into scalable products that improve patient outcomes. He has contributed to the development of early digital therapeutics for executive dysfunction as part of clinical research into neuroplasticity for veterans with TBI while at the San Francisco VA in addition to providing court-ordered forensic evaluations for youth in the juvenile justice system.

Ryan earned his Psy.D. in Clinical Psychology with an emphasis in Neuropsychology from the California Institute of Integral Studies. He completed residency training at California Pacific Medical Center including postdoctoral specializations in Neuropsychology, Cognitive Rehabilitation and Health Psychology, and holds a bachelor's degree from Duke University.

作者簡介(中文翻譯)

Shivan Bhavnani 是一位專注於重塑心理健康護理的醫療投資者。作為 Evio VC 的合夥人,他支持在心理健康護理領域創新的早期公司。他還創立了 GIMBHI,一個獨立的研究機構,其見解曾出現在 NatureAxiosBusiness InsiderEntrepreneur 和 Bessemer Venture Partners 等媒體上。

Shivan 是全球健康科技會議的常規演講者,曾擔任多家初創公司和組織的戰略顧問,包括 One Mind Accelerator、ReKlame Health 等。在過去十年中,Shivan 在風險投資、生物科技和信貸領域工作。

Shivan 獲得了杜克大學的 MBA 學位和衛斯理大學的學士學位。此外,他還在哥倫比亞精神醫學院完成了創新獎學金。他也是一名特許替代投資分析師 (CAIA)。

Ryan McKim,心理學博士 (Psy.D.),是 GIMBHI 顧問網絡中 Innovative Growth Capital 的風險顧問,指導創始人在突破性心理健康技術的資本策略和市場准入方面。作為一名在健康科技領域擁有超過二十年經驗的資深運營者和投資者,他幫助數字治療、神經技術和迷幻藥物初創公司從種子階段擴展到商業化。

除了投資工作外,Ryan 仍然是一名活躍的臨床醫生。目前,他擔任馬林縣成人複雜共病物質使用障礙和嚴重心理疾病的物質使用治療計劃的監督者,以及一家私人整合精神病學診所的醫生,並曾在加州太平洋醫療中心的精神科工作,為患有神經退行性疾病、中樞神經系統疾病、創傷性腦損傷 (TBI) 和情緒障礙的成年人提供全面的神經心理評估和基於證據的干預。他的雙重視角——臨床醫生和風險投資家——使他能夠將嚴謹的神經科學轉化為可擴展的產品,以改善患者的結果。他曾在舊金山退伍軍人醫院參與針對創傷性腦損傷退伍軍人的神經可塑性臨床研究,為執行功能障礙的早期數字治療的開發做出貢獻,並為青少年司法系統中的青少年提供法院命令的法醫評估。

Ryan 獲得了加州整合研究所的臨床心理學博士學位,專注於神經心理學。他在加州太平洋醫療中心完成了住院醫師培訓,包括神經心理學、認知康復和健康心理學的博士後專業化,並擁有杜克大學的學士學位。